Brief: Nextcell Pharma Q4 loss widens to SEK 4.8 mln
Oct 31 (Reuters) - NEXTCELL PHARMA AB NEXTCL.ST :
* REPORTS A LOSS OF SEK -4,757,996 IN ITS Q4 AND A LOSS OF
SEK
-13,245,206 FOR ENTIRE FINANCIAL YEAR
Source text for Eikon: ID:nWkr6mQ3SL
Further company coverage: NEXTCL.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 587720920;))
Recent news on NextCell Pharma AB
See all newsBrief: NextCell Pharma Q1 Operating Income At SEK 2.8 Million
Brief: Nextcell Pharma Q4 Operating Income SEK 1.8 Mln
Brief: Nextcell Pharma Says ProTrans Data Show Insulin Production Preservation
Brief: NextCell Board Proposes Directed Issue Of 15,000,000 Shares
Brief: Nextcell Decides To Propose Directed Share Issue Of SEK 15 Mln